A Prospective Clinical Study of Zeprumetosta in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

​ Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides/Sézary Syndrome

Interventions: Drug: Zeprumetostat Tablets

Sponsors: Peking University First Hospital; Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides/Sézary Syndrome
Interventions: Drug: Zeprumetostat Tablets
Sponsors: Peking University First Hospital; Jiangsu Hengrui Pharmaceutical Co., Ltd.
Not yet recruiting